Washington Trust Bank Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Washington Trust Bank lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 6.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 36,061 shares of the pharmaceutical company’s stock after selling 2,315 shares during the quarter. Vertex Pharmaceuticals comprises approximately 1.3% of […]

Related Keywords

Washington ,United States ,Canada ,Piper Sandler ,Brucei Sachs ,Reshma Kewalramani ,Washington Trust Bank ,Vertex Pharmaceuticals ,Blair William Co ,Quarter For Vertex Pharmaceuticals ,Royal Bank ,Vertex Pharmaceuticals Company Profile ,A Davidson ,Da Davidson ,Vertex Pharmaceuticals Incorporated ,Vertex Pharmaceuticals Stock Performance ,Ellevest Inc ,Cantor Fitzgerald ,News Ratings For Vertex Pharmaceuticals Daily ,Insider Transactions At Vertex Pharmaceuticals ,Securities Exchange Commission ,Free Report ,Trust Bank ,Pharmaceuticals Incorporated ,Get Free Report ,Exchange Commission ,Director Bruce ,Visit Holdingschannel ,Vertex Pharmaceuticals Daily ,